financetom
Business
financetom
/
Business
/
Masimo smartwatches infringe Apple design patents, US jury says
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Masimo smartwatches infringe Apple design patents, US jury says
Nov 3, 2024 12:04 PM

Oct 25 (Reuters) - Apple ( AAPL ) convinced a federal

jury on Friday that health monitoring tech company Masimo's ( MASI )

smartwatches infringe two of its design patents.

The jury, in Delaware, agreed with Apple ( AAPL ) that Masimo's ( MASI ) W1

and Freedom watches and chargers willfully violated Apple's ( AAPL )

patent rights in smartwatch designs, awarding the tech giant

$250 in damages. Apple's ( AAPL ) attorneys told the court the "ultimate

purpose" of its lawsuit was to win an injunction against sales

of Masimo's ( MASI ) smartwatches after an infringement ruling.

The jury also determined that Masimo's ( MASI ) watches did not

infringe Apple ( AAPL ) patents covering smartwatch inventions that the

tech giant had accused Masimo ( MASI ) of copying.

Masimo ( MASI ) said in a statement that the company appreciated the

jury's verdict "in favor of Masimo ( MASI ) and against Apple ( AAPL ) on nearly

all issues," and that the decision only applied to a

"discontinued module and charger."

"Apple ( AAPL ) primarily sought an injunction against Masimo's ( MASI )

current products, and the jury's verdict is a victory for Masimo ( MASI )

on that issue," Masimo ( MASI ) said.

Apple ( AAPL ) said in a statement that it was "glad the jury's

decision today will protect the innovations we advance on behalf

of our customers."

Irvine, California-based Masimo ( MASI ) accused Apple ( AAPL ) of hiring

away its employees and stealing its pulse oximetry technology

after discussing a potential collaboration. Masimo ( MASI ) convinced the

U.S. International Trade Commission last year to block imports

of Apple's ( AAPL ) Series 9 and Ultra 2 smartwatches after the

commission found that their technology for reading blood oxygen

levels infringed Masimo's ( MASI ) patents.

Apple ( AAPL ) has appealed the decision and resumed selling the

watches after removing the technology. The tech giant

countersued Masimo ( MASI ) for patent infringement in 2022, alleging

that Masimo ( MASI ) copied Apple Watch features to use in its

smartwatches.

Apple ( AAPL ) also accused Masimo ( MASI ) of using lawsuits at the ITC

and in California to "make way for Masimo's ( MASI ) own watch." Masimo ( MASI )

said Apple's ( AAPL ) patent lawsuit was "retaliatory" and "an attempt to

avoid the court in which the parties have been litigating their

dispute."

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Forbes India Rich List 2023: A look at India's wealth landscape as new faces, returning titans reshape the richest 100
Forbes India Rich List 2023: A look at India's wealth landscape as new faces, returning titans reshape the richest 100
Oct 12, 2023
Forbes India Richest List 2023: While Mukesh Ambani reclaims the top spot with $92 billion in India's richest list, followed by Gautam Adani at $68 billion, tech mogul Shiv Nadar climbs to No. 3. There is a notable shift in wealth, attributed to market dynamics and key business moves and the minimum net worth for India's richest club hits a record $2.3 billion.
Tea industry in acute financial crisis, says Indian tea planters' body
Tea industry in acute financial crisis, says Indian tea planters' body
Oct 12, 2023
While the tea prices increased at a compound annual growth rate (CAGR) of around 4% over the past decade, the cost of inputs like gas and coal grew at a CAGR of 9-15%, the Indian Tea Association (ITA) said in its status paper 'Tea Scenario 2023.'
ZEE-Sony Merger: NCLAT defers hearing of Axis Finance plea against merger
ZEE-Sony Merger: NCLAT defers hearing of Axis Finance plea against merger
Sep 14, 2023
Notably in September first week, private lender IDBI Bank has filed an appeal against the NCLT order approving the merger. The lender has moved the NCLAT  against the order. Earlier, the Mumbai bench of the NCLT on August 10, 2023, approved the proposed merger, which would create the largest media entity in the country. The approval came nearly two years after the merger was announced in December 2021.
Bhagiradha Chemicals aims to triple turnover in five years to Rs 1,500 crore
Bhagiradha Chemicals aims to triple turnover in five years to Rs 1,500 crore
Oct 12, 2023
Bhagiradha Chemicals & Industries, under the leadership of CEO & COO A Arvind Kumar, is setting its sights on tripling its revenue within the next five years.
Copyright 2023-2026 - www.financetom.com All Rights Reserved